I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Low-dose AZA Combined With Short Term CAG Derived Regimen as a Bridging Treatment in Patients With Advanced MDS Prior to Allo-HSCT
This single arm, prospective study on the feasibility of a bridging treatment with low-dose azacitidine (AZA) in combination with short term CAG derived regimen prior to allogeneic stem cell transplantation (allo-HSCT) in patients with advanced myelodysplastic syndromes (MDS) .
myelodysplastic syndromes
stem cell transplantation
cell transplantation
raeb
cag protocol
- 0 views
- 19 Feb, 2024
- 1 location